AI could help doctors pick better diabetes drugs

NCT ID NCT07684690

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence (AI) tool can help doctors choose better diabetes medicines for patients with type 2 diabetes. Many patients are treated by doctors who are not diabetes specialists, so the AI provides real-time suggestions and predictions about which medications might work best. Patients with poorly controlled blood sugar are randomly assigned to have their doctor use the AI tool or prescribe as usual. The study follows patients for 12 months to see if the AI leads to better blood sugar control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-assisted antidiabetic drug consultation system
What this could lead to
If successful, this AI tool could help non-specialist doctors prescribe more effective diabetes medications, leading to better blood sugar control for many patients.
What could go wrong
The AI only provides suggestions, and doctors may not follow them. The study is relatively small and results may not apply to all populations or healthcare settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Taiwan University Hospital

    Taipei, 100, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.